What dose of CoQ10 is safe with Clopidogrel and Apixaban (Elequis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CoQ10 Dosing with Clopidogrel and Apixaban

Standard CoQ10 doses of 100-200 mg/day are safe to use with both clopidogrel and apixaban, as CoQ10 does not interact with either medication's metabolism or increase bleeding risk. 1

No Drug Interactions with Apixaban

  • CoQ10 does not affect apixaban's metabolism through CYP3A4 enzymes or P-glycoprotein transporters at therapeutic doses, ensuring safe co-administration. 1

  • No additional INR or bleeding monitoring is required specifically for the CoQ10-apixaban combination, as there is no documented interaction. 1

  • The combination of apixaban and clopidogrel itself carries similar bleeding risk regardless of CoQ10 supplementation, with major bleeding rates of approximately 7-8 per 100 person-years. 2

Recommended CoQ10 Dosing

  • Take 100-200 mg/day of CoQ10 for cardiovascular support in patients with cardiometabolic disorders. 1, 3

  • Administer CoQ10 with fat-containing meals to enhance absorption, as it is a lipophilic compound with poor intestinal absorption. 1

  • CoQ10 demonstrates remarkable safety even at very high doses, with doses up to 3000 mg/day for 8 months being well-tolerated. 4, 3

  • The acceptable daily intake (ADI) is 12 mg/kg/day, which equals 720 mg/day for a 60 kg person, and the observed safety level (OSL) is 1200 mg/day. 5

Monitoring Recommendations

  • Monitor liver enzymes during CoQ10 supplementation, particularly at higher doses or with prolonged use, as elevated liver enzymes have been reported. 1, 4, 3

  • No specific bleeding monitoring is needed for CoQ10 when combined with apixaban and clopidogrel beyond standard monitoring for dual antiplatelet/anticoagulant therapy. 1

Important Caveats

  • Focus bleeding risk management on avoiding strong dual CYP3A4 and P-gp inhibitors or inducers with apixaban (such as ketoconazole, clarithromycin, ritonavir, rifampin, carbamazepine, and phenytoin), rather than worrying about CoQ10. 1

  • The primary concern with clopidogrel and apixaban combination therapy is the inherent bleeding risk from dual antiplatelet/anticoagulant therapy itself, not CoQ10 supplementation. 2, 6

  • CoQ10 has a potential interaction with warfarin (not relevant here), but this does not apply to direct oral anticoagulants like apixaban. 4

References

Guideline

CoQ10 and Apixaban Interaction Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Coenzyme Q10 Supplementation in Multiple Sclerosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

CoQ10 Contraindications and Safety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Safety assessment of coenzyme Q10 (CoQ10).

BioFactors (Oxford, England), 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.